LLY

734.37

-0.09%↓

JNJ

176.67

-0.01%↓

ABBV

208.05

-0.2%↓

UNH

303.9

+1.02%↑

AZN

79.94

-0.17%↓

LLY

734.37

-0.09%↓

JNJ

176.67

-0.01%↓

ABBV

208.05

-0.2%↓

UNH

303.9

+1.02%↑

AZN

79.94

-0.17%↓

LLY

734.37

-0.09%↓

JNJ

176.67

-0.01%↓

ABBV

208.05

-0.2%↓

UNH

303.9

+1.02%↑

AZN

79.94

-0.17%↓

LLY

734.37

-0.09%↓

JNJ

176.67

-0.01%↓

ABBV

208.05

-0.2%↓

UNH

303.9

+1.02%↑

AZN

79.94

-0.17%↓

LLY

734.37

-0.09%↓

JNJ

176.67

-0.01%↓

ABBV

208.05

-0.2%↓

UNH

303.9

+1.02%↑

AZN

79.94

-0.17%↓

Search

Hologic Inc

Cerrado

SectorSalud

66.72 0.11

Resumen

Variación precio

24h

Actual

Mínimo

66.07

Máximo

66.91

Métricas clave

By Trading Economics

Ingresos

212M

195M

Ventas

19M

1B

P/B

Media del Sector

27.855

35.724

BPA

1.08

Margen de beneficio

19.037

Empleados

7,063

EBITDA

341M

334M

Recomendaciones

By TipRanks

Recomendaciones

Comprar

Estimación a 12 meses

+12.11% upside

Dividendos

By Dow Jones

Próximas Ganancias

3 nov 2025

Estadísticas de Mercado

By TradingEconomics

Capitalización de Mercado

292M

15B

Apertura anterior

66.61

Cierre anterior

66.72

Noticias sobre sentimiento de mercado

By Acuity

29%

71%

65 / 372 Clasificación en Healthcare

Puntuación técnica

By Trading Central

Confianza

Bullish Evidence

Hologic Inc Gráfico

El rendimiento pasado no es un indicador fiable de resultados futuros.

Noticias Relacionadas

27 may 2025, 18:46 UTC

Principales Movimientos del Mercado
Adquisiciones, fusiones, absorciones

Hologic Shares Up Following Report of Buyout Offer From TPG, Blackstone

27 may 2025, 20:07 UTC

Adquisiciones, fusiones, absorciones

Hologic Stock Is Surging. Why Shares of the MedTech Company Are Up 14%. -- Barrons.com

27 may 2025, 19:06 UTC

Adquisiciones, fusiones, absorciones

Hologic Stock Is Surging. Why Shares of the MedTech Company Are Up 14%. -- Barrons.com

27 may 2025, 18:26 UTC

Adquisiciones, fusiones, absorciones

Hologic Stock Is Surging. Why Shares of the MedTech Company Are Up 19%. -- Barrons.com

Comparación entre iguales

Cambio de precio

Hologic Inc Esperado

Precio Objetivo

By TipRanks

12.11% repunte

Estimación a 12 meses

Media 74.7 USD  12.11%

Máximo 87 USD

Mínimo 69 USD

De acuerdo con 14 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Hologic Inc Dist en los últimos 3 meses.

Consenso

By TipRanks

Comprar

14 ratings

7

Comprar

7

Mantener

0

Vender

Puntuación técnica

By Trading Central

52.69 / 58.605Soporte y Resistencia

Corto Plazo

Bullish Evidence

Medio plazo

Weak Bearish Evidence

Largo Plazo

Bearish Evidence

Sentimiento

By Acuity

65 / 372 Clasificación en Salud

Noticias sobre sentimiento de mercado

Coyuntura alcista

Volatilidad

Por debajo de la media

Volumen de Noticias (RCV)

Por debajo de la media

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

$

Acerca de Hologic Inc

Hologic, Inc. engages in the development, manufacture, and supply of diagnostics products, medical imaging systems, and surgical products for women's health through early detection and treatment worldwide. The company operates through four segments: Diagnostics, Breast Health, GYN Surgical, and Skeletal Health. It provides Aptima molecular diagnostic assays to detect the infectious microorganisms; Aptima viral load assays for Hepatitis B virus, Hepatitis C virus, human immunodeficiency virus, and human cytomegalo virus; Aptima bacterial vaginosis and candida vaginitis assays for the diagnosis of vaginitis; Aptima SARS-CoV-2 and Panther Fusion SARS-CoV-2 assays to detect SARS-CoV-2; ThinPrep System for cytology applications; and Rapid Fetal Fibronectin Test that assists physicians in assessing the risk of pre-term birth. The company also offers breast cancer care solutions in the areas of radiology, breast surgery, pathology, and treatment, such as 3D digital mammography systems, image analytics software, reading workstations, minimally invasive breast biopsy guidance systems, breast biopsy site markers, localization, and specimen radiology solutions; and breast conserving surgery products. In addition, it provides MyoSure Hysteroscopic Tissue Removal System for the removal of fibroids and polyps in the uterus; NovaSure Endometrial Ablation System to treat abnormal uterine bleeding; Fluent Fluid Management System that provides liquid distention during diagnostic and operative hysteroscopic procedures; Acessa ProVu system to treat various fibroids; and CoolSeal portfolio, such as bipolar vessel sealing devices. Further, it offers Horizon DXA, a dual energy X-ray system; and Fluoroscan Insight FD mini C-arm to perform minimally invasive orthopedic surgical procedures. It sells its products through direct sales, service forces, independent distributors, and sales representatives. The company was incorporated in 1985 and is headquartered in Marlborough, Massachusetts.